Malar J

Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C
Malar J, (2010). 9:164

The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity?.Chuma J, Okungu V, Molyneux C
Malar J, (2010). 9:149

Barriers to prompt and effective malaria treatment among the poorest population in Kenya.Chuma J, Okungu V, Molyneux C
Malar J, (2010). 9:144

The relationship between reported fever and Plasmodium falciparum infection in African children.Okiro EA, Snow RW
Malar J, (2010). 9:99

Engaging diverse communities participating in clinical trials: case examples from across Africa.Nyika A, Chilengi R, Ishengoma D, Mtenga S, Thera MA, Sissoko MS, Lusingu J, Tiono AB, Doumbo O, Sirima SB, Lemnge M, Kilama WL
Malar J, (2010). 9:86

Distribution of the main malaria vectors in Kenya.Okara RM, Sinka ME, Minakawa N, Mbogo CM, Hay SI, Snow RW
Malar J, (2010). 9:69

Retail sector distribution chains for malaria treatment in the developing world: a review of the literature.Patouillard E, Hanson KG, Goodman CA
Malar J, (2010). 9:50

Plasmodium infection and its risk factors in eastern Uganda.Pullan RL, Bukirwa H, Staedke SG, Snow RW, Brooker S
Malar J, (2010). 9:2

Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage.Kihara M, Carter JA, Holding PA, Vargha-Khadem F, Scott RC, Idro R, Fegan GW, de Haan M, Neville BG, Newton CR
Malar J, (2009). 8:273

Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets.Chuma J, Abuya T, Memusi D, Juma E, Akhwale W, Ntwiga J, Nyandigisi A, Tetteh G, Shretta R, Amin A
Malar J, (2009). 8:243

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.Kinyanjui SM, Bejon P, Osier FH, Bull PC, Marsh K
Malar J, (2009). 8:242

The use of schools for malaria surveillance and programme evaluation in Africa.Brooker S, Kolaczinski JH, Gitonga CW, Noor AM, Snow RW
Malar J, (2009). 8:231

Defining the relationship between Plasmodium falciparum parasite rate and clinical disease: statistical models for disease burden estimation.Patil AP, Okiro EA, Gething PW, Guerra CA, Sharma SK, Snow RW, Hay SI
Malar J, (2009). 8:186

Space-time variation of malaria incidence in Yunnan province, China.Clements AC, Barnett AG, Cheng ZW, Snow RW, Zhou HN
Malar J, (2009). 8:180

Fever treatment in the absence of malaria transmission in an urban informal settlement in Nairobi, Kenya.Ye Y, Madise N, Ndugwa R, Ochola S, Snow RW
Malar J, (2009). 8:160

Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolates.Blythe JE, Niang M, Marsh K, Holder AA, Langhorne J, Preiser PR
Malar J, (2009). 8:140

How equitable is bed net ownership and utilisation in Tanzania? A practical application of the principles of horizontal and vertical equity.Matovu F, Goodman C, Wiseman V, Mwengee W
Malar J, (2009). 8:109

Chloroquine resistance before and after its withdrawal in Kenya.Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A
Malar J, (2009). 8:106

Health service providers in Somalia: their readiness to provide malaria case-management.Noor AM, Rage IA, Moonen B, Snow RW
Malar J, (2009). 8:100

Endemicity response timelines for Plasmodium falciparum elimination.Smith DL, Hay SI
Malar J, (2009). 8:87